Back to GetFilings.com




QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

FOR QUARTERLY AND TRANSITION REPORTS
PURSUANT TO SECTIONS 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934


ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2003

OR

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                             to                              

Commission file number 000-50010


DADE BEHRING HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

DELAWARE
(State or Other Jurisdiction of Incorporation or Organization)
  36-3989270
(I.R.S. Employer Identification No.)

1717 DEERFIELD ROAD,
DEERFIELD ILLINOIS

(Address of Principal Executive Offices)

 

60015
(Zip Code)

(847) 267-5300
(Registrant's telephone number, including area code)

        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

        Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes o No ý


APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

        Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13, or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ý No o

        Number of Shares of Common Stock, par value $0.01 per share, Outstanding at August 8, 2003: 40,073,732.





DADE BEHRING HOLDINGS, INC.
JUNE 30, 2003 FORM 10-Q—TABLE OF CONTENTS


 

 

 

 

PAGE
PART I   FINANCIAL INFORMATION    

Item 1.

 

Financial Statements

 

3

 

 

Condensed Consolidated Balance Sheets as of June 30, 2003 (unaudited) and December 31, 2002 (Successor Company)

 

3

 

 

Condensed Consolidated Statements of Operations and Comprehensive Income (unaudited) for the quarters ended June 30, 2003 (Successor Company) and June 30, 2002 (Predecessor Company)

 

4

 

 

Condensed Consolidated Statements of Operations and Comprehensive Income (unaudited) for the six-months ended June 30, 2003 (Successor Company) and June 30, 2002 (Predecessor Company)

 

5

 

 

Condensed Consolidated Statement of Changes in Shareholders' Equity for the six-months ended June 30, 2003 (unaudited) (Successor Company)

 

6

 

 

Condensed Consolidated Statements of Cash Flows (unaudited) for the six-months ended June 30, 2003 (Successor Company) and June 30, 2002 (Predecessor
Company)

 

7

 

 

Notes to Condensed Consolidated Financial Statements (unaudited)

 

8

Item 2.

 

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

26

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

33

Item 4.

 

Controls and Procedures

 

33

PART II

 

OTHER INFORMATION

 

 

Item 4.

 

Submission of Matters to a Vote of Security Holders

 

34

Item 6.

 

Exhibits and Reports on Form 8-K

 

35

 

 

Signature

 

36

2



PART I

ITEM 1. FINANCIAL STATEMENTS.


Dade Behring Holdings, Inc.

Condensed Consolidated Balance Sheets

 
   
  Successor Company
 
 
  Successor Company
 
 
  December 31, 2002
 
 
  June 30, 2003
 
 
  (unaudited)

   
 
 
  (Dollars in millions, except
share-related data)

 
Assets              
Current assets:              
  Cash and cash equivalents   $ 77.7   $ 35.5  
  Restricted cash     8.7     7.9  
  Accounts receivable, net     283.8     289.7  
  Inventories     178.6     174.3  
  Prepaid expenses     14.8     18.9  
  Deferred income taxes     0.9     0.4  
   
 
 
Total current assets     564.5     526.7  
Property, plant and equipment, net     397.9     390.5  
Debt issuance costs, net     12.7     14.0  
Deferred income taxes     7.5     3.5  
Identifiable intangible assets, net     410.7     414.3  
Goodwill, net     524.7     543.0  
Other assets     29.8     26.8  
   
 
 
Total assets   $ 1,947.8   $ 1,918.8  
   
 
 
Liabilities and Shareholders' Equity              
Current liabilities:              
  Short-term debt   $ 3.3   $ 6.1  
  Current portion of long-term debt         5.0  
  Accounts payable     74.8     76.8  
  Accrued liabilities     222.8     228.5  
   
 
 
Total current liabilities     300.9     316.4  
Long-term debt     747.3     760.7  
Deferred income taxes     120.7     122.6  
Other liabilities     148.7     131.0  
   
 
 
Total liabilities     1,317.6     1,330.7  
   
 
 
Commitments and contingencies              
Shareholders' equity:              
Successor Company Common Stock: $.01 par value; 65,000,000 and 50,000,000 shares authorized at June 30, 2003 and December 31, 2002, respectively; 40,071,572 and 39,929,479 shares issued and outstanding at June 30, 2003 and December 31, 2002, respectively     0.4     0.4  
Additional paid-in capital     645.8     643.1  
Unearned stock-based compensation     (0.1 )    
Accumulated deficit     (22.8 )   (48.6 )
Accumulated other comprehensive income (loss)     6.9     (6.8 )
   
 
 
Total shareholders' equity     630.2     588.1  
   
 
 
Total liabilities and shareholders' equity   $ 1,947.8   $ 1,918.8  
   
 
 

The accompanying notes are an integral part of the condensed consolidated financial statements.

3



Dade Behring Holdings, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income

 
  Successor Company
  Predecessor Company
 
 
  Quarter Ended June 30, 2003
  Quarter Ended
June 30, 2002

 
 
  (unaudited)

  (unaudited)

 
 
  (Dollars in millions, except
per share data)

 
Net sales   $ 361.7   $ 318.0  
Cost of goods sold     169.2     156.5  
   
 
 
Gross profit     192.5     161.5  
Operating costs and expenses:              
  Marketing and administrative expenses     121.0     108.1  
  Research and development expenses     30.5     22.4  
  Cost reduction programs expense         0.9  
  Restructuring expense, net         (0.5 )
   
 
 
Income from operations     41.0     30.6  
Other (expense) income:              
  Interest expense     (20.5 )   (32.2 )
  Interest income     0.9     0.8  
  Balance sheet restructuring costs         (8.7 )
  Foreign exchange gain     1.8     4.0  
  Other         (0.5 )
   
 
 
Income (loss) before income tax     23.2     (6.0 )
Income tax expense     8.2     1.9  
   
 
 
Net income (loss)     15.0     (7.9 )
   
 
 
Other comprehensive income (loss), net of income tax:              
  Foreign currency translation adjustments     10.2     8.1  
  Net (loss) income on derivative instruments     (5.0 )   0.1  
   
 
 
Other comprehensive income, net of income tax     5.2     8.2  
   
 
 
Comprehensive income   $ 20.2   $ 0.3  
   
 
 
Basic net income per Successor Company common share:   $ 0.37        
Diluted net income per Successor Company common share:   $ 0.36        
Basic and diluted net loss per Predecessor Company Class L and Common shares:         $ (0.18 )

The accompanying notes are an integral part of the condensed consolidated financial statements.

4



Dade Behring Holdings, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income

 
  Successor Company
  Predecessor Company
 
 
  Six-months Ended
June 30, 2003

  Six-months Ended
June 30, 2002

 
 
  (unaudited)

  (unaudited)

 
 
  (Dollars in millions, except
per share data)

 
Net sales   $ 704.4   $ 624.2  
Cost of goods sold     333.1     304.7  
   
 
 
Gross profit     371.3     319.5  
Operating costs and expenses:              
  Marketing and administrative expenses     234.6     207.1  
  Research and development expenses     56.3     41.2  
  Cost reduction programs expense         1.9  
  Restructuring expense, net         1.4  
   
 
 
Income from operations     80.4     67.9  
Other (expense) income:              
  Interest expense     (40.4 )   (62.9 )
  Interest income     1.8     1.7  
  Balance sheet restructuring costs         (12.5 )
  Foreign exchange loss     (0.4 )   (1.4 )
  Other     (0.6 )   (2.5 )
   
 
 
Income (loss) before income tax     40.8     (9.7 )
Income tax expense     15.0     2.6  
   
 
 
Income (loss) before cumulative effect of change in accounting principle     25.8     (12.3 )
Cumulative effect of change in accounting principle, net of tax         20.0  
   
 
 
Net income     25.8     7.7  
   
 
 
Other comprehensive income (loss), net of income tax:              
  Foreign currency translation adjustments     20.2     7.8  
  Net (loss) income on derivative instruments     (6.5 )   0.1  
   
 
 
Other comprehensive income, net of income tax     13.7     7.9  
   
 
 
Comprehensive income   $ 39.5   $ 15.6  
   
 
 
Basic net income per Successor Company common share:   $ 0.64        
Diluted net income per Successor Company common share:   $ 0.62        
Basic and diluted income (loss) per Predecessor Company Class L and Common shares:              
  Loss before cumulative effect of change in accounting principle         $ (0.27 )
  Cumulative effect of change in accounting principle           0.40  
         
 
  Net income         $ 0.13  
         
 

The accompanying notes are an integral part of the condensed consolidated financial statements.

5



Dade Behring Holdings, Inc.

Condensed Consolidated Statement of Changes in Shareholders' Equity

(Unaudited)

(Dollars in millions, except share-related data)

 
  Common Stock
   
   
   
  Accumulated
Other
Comprehensive
Income (Loss)

   
 
 
  Additional
Paid-in
Capital

  Unearned
Stock-Based
Compensation

  Accumulated
Deficit

  Total
Shareholders'
Equity

 
 
  Shares
  Amount
 
Balance at December 31, 2002   39,929,479   $ 0.4   $ 643.1   $   $ (48.6 ) $ (6.8 ) $ 588.1  
Net income                   25.8         25.8  
Issuance of stock   70,588         1.3                 1.3  
Issuance of stock options           0.3     (0.3 )            
Exercise of stock options   71,505         1.1                 1.1  
Amortization of unearned stock-based compensation               0.2             0.2  
Net loss on derivative instruments, net of income taxes                       (6.5 )   (6.5 )
Foreign currency translation adjustment                       20.2     20.2  
   
 
 
 
 
 
 
 
Balance at June 30, 2003   40,071,572   $ 0.4   $ 645.8   $ (0.1 ) $ (22.8 ) $ 6.9   $ 630.2  
   
 
 
 
 
 
 
 

The accompanying notes are an integral part of the condensed consolidated financial statements.

6



Dade Behring Holdings, Inc.

Condensed Consolidated Statements of Cash Flows

 
  Successor Company
  Predecessor Company
 
 
  Six-months Ended
June 30, 2003

  Six-months Ended
June 30, 2002

 
 
  (Unaudited)

  (Unaudited)

 
 
  (Dollars in millions)

 
Operating Activities:              
Net income   $ 25.8   $ 7.7  
Adjustments to reconcile net income to net cash provided by operating activities:              
  Cumulative effect of change in accounting principle         (20.0 )
  Depreciation and amortization expense     65.8     56.0  
  Net loss on disposal of fixed assets     1.6     3.8  
  Stock-based compensation expense     1.5     0.8  
  Deferred income taxes     10.0     0.1  
  Changes in balance sheet items:              
    Accounts receivable, net     20.2     (22.9 )
    Inventories     2.8     8.4  
    Prepaid expenses     4.6     0.3  
    Accounts payable     (4.9 )   (18.7 )
    Accrued liabilities     (21.9 )   4.5  
    Other, net     2.0     12.2  
   
 
 
Net cash flow provided by operating activities     107.5     32.2  

Investing Activities:

 

 

 

 

 

 

 
Capital expenditures     (45.3 )   (38.3 )
   
 
 
Net cash flow utilized for investing activities     (45.3 )   (38.3 )
   
 
 
Net cash flow provided (utilized) before financing activities     62.2     (6.1 )

Financing Activities:

 

 

 

 

 

 

 
(Increase) decrease in restricted cash     (0.1 )   1.8  
Net repayments related to short-term debt     (2.9 )   (4.3 )
Repayments of borrowings under new bank credit agreement     (20.0 )    
Proceeds from exercise of stock options     1.1      
Repayments of borrowings related to former revolving credit facility         (6.2 )
Repayments of borrowings under former bank credit agreement         (17.5 )
   
 
 
Net cash flow utilized for financing activities     (21.9 )   (26.2 )
Effect of foreign exchange rates on cash     1.9     1.9  
   
 
 
Net increase (decrease) in cash and cash equivalents     42.2     (30.4 )

Cash and Cash Equivalents:

 

 

 

 

 

 

 
Beginning of Period     35.5     86.8  
   
 
 
End of Period   $ 77.7   $ 56.4  
   
 
 

The accompanying notes are an integral part of the condensed consolidated financial statements.

7



Dade Behring Holdings, Inc.

Notes To Condensed Consolidated Financial Statements (unaudited)

1.    Organization, Business and Plan of Reorganization

        Dade Behring Holdings, Inc., was incorporated in the State of Delaware on September 23, 1994 and owns all the capital stock of its subsidiary, Dade Behring Inc. ("DBI"), formerly Dade International Inc. (collectively, the "Company"). The Company develops, manufactures and markets in vitro diagnostic ("IVD") equipment, reagents, consumable supplies and services worldwide.

        Prior to the reorganization described below, Bain Capital, Inc., GS Capital Partners, L.P. (an affiliate of Goldman Sachs Group, L.P.), their respective related investors, Aventis S.A. and certain of its affiliates ("Aventis S.A.") and the management of the Company owned substantially all the capital stock of the Company.

        On August 1, 2002, Dade Behring Holdings, Inc. and certain of its wholly-owned direct and indirect domestic subsidiaries, including DBI, filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code, as amended, with the United States Bankruptcy Court for the Northern District of Illinois ("Bankruptcy Court"). The companies party to the bankruptcy proceedings are collectively referred to as the "Debtors." On August 1, 2002, the Debtors filed their Disclosure Statement for their Joint Chapter 11 Plan of Reorganization ("POR"). No other subsidiaries of Dade Behring Holdings, Inc., which primarily operate outside of the United States filed for relief under the United States Bankruptcy Code. On September 18, 2002, the Bankruptcy Court confirmed the POR. All conditions under the confirmation of the POR were subsequently met, and the POR became effective on October 3, 2002, resulting in the Debtors effecting a new capital structure. The POR and associated new senior credit agreement / capital structure provided for the following:

        The Company is restricted by its debt agreements from loaning or paying cash dividends, except in limited circumstances defined therein.

8



2.    Basis of Presentation

        The condensed consolidated financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such regulations. The Company believes the disclosures included in the unaudited condensed consolidated financial statements, when read in conjunction with the December 31, 2002 consolidated financial statements of the Company included in the Company's 2002 Annual Report on Form 10-K and notes thereto, are adequate to make the information presented not misleading. Certain reclassifications have been made to prior period balances to conform to the current year presentation. In management's opinion, the condensed consolidated financial statements reflect all adjustments, consisting solely of normal recurring adjustments, necessary to summarize fairly the consolidated financial position, results of operations, and cash flows for such periods. The results of operations for the quarter and six-months ended June 30, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31, 2003.

Fresh-Start Reporting

        Upon emergence from bankruptcy, the consolidated financial statements of the Company are presented in accordance with the American Institute of Certified Public Accountants Statement of Position 90-7: "Financial Reporting by Entities in Reorganization under the Bankruptcy Code" ("SOP 90-7"). In conformity with the procedures specified by Statement of Financial Accounting Standards ("SFAS") No. 141, "Business Combinations," the Company allocated reorganization value to net assets and any excess of reorganization value not allocated to specific tangible or identified intangible assets is reported as an intangible asset representing reorganization value in excess of amounts allocable to identifiable assets. The Company has included such amount in goodwill, in accordance with SFAS No. 142, "Goodwill and Other Intangible Assets." All liabilities existing at the POR confirmation date, other than deferred taxes, are required to be stated at present values of amounts to be paid. New accounting pronouncements that will be required in the financial statements within twelve months following the adoption of fresh-start accounting have been adopted at the same time fresh-start reporting was adopted.

        Although the POR became effective on October 3, 2002, for financial reporting convenience purposes, the Company recorded the adjustments necessitated by SOP 90-7 on October 1, 2002. As a result of the Company's emergence from Chapter 11 bankruptcy and the application of fresh-start reporting, consolidated financial statements for the Company for the periods commencing on October 2, 2002 are referred to as the "Successor Company" and are not comparable with any periods prior to October 1, 2002, which are referred to as the "Predecessor Company." Aside from the effects of fresh-start reporting and new accounting pronouncements adopted on October 2, 2002, the Successor Company follows the same accounting policies as the Predecessor Company. All references in these notes to the quarter ended and six-months ended June 30, 2002 are to the Predecessor Company. All references to the quarter ended and six-months ended June 30, 2003 are to the Successor Company.

        SOP 90-7 provides that reductions in deferred tax asset valuation allowances that existed at the date fresh-start reporting was applied are first credited to goodwill. Accordingly, $18.3 million of decreases to certain deferred tax asset valuation allowances during the six-months ended June 30, 2003 resulted in a corresponding reduction to goodwill. The decreases to certain deferred tax asset valuation allowances are due to the utilization of net operating loss carryforwards, predominantly in the U.S.

9


Balance Sheet Restructuring Costs

        The Company has recorded all incremental professional and bank fees directly associated with the reorganization of the Company's balance sheet incurred prior to the bankruptcy filing on August 1, 2002 in a separate line item on the Condensed Consolidated Statement of Operations titled "Balance Sheet Restructuring Costs." For the quarters ended and six-months ended June 30, 2003 and 2002, balance sheet restructuring costs included the following (in millions):

 
  Quarter ended
June 30, 2003

  Quarter ended
June 30, 2002

  Six-months ended
June 30, 2003

  Six-months ended
June 30, 2002

Professional fees   $   $ 6.3   $   $ 9.6
Bank fees not associated with the new debt facilities         1.1         1.5
Other         1.3         1.4
   
 
 
 
    $   $ 8.7   $   $ 12.5
   
 
 
 

Earnings Per Share

        The computation of basic and diluted income per share for the Successor Company is set forth in the following table (dollars in millions, except for share data).

 
  Quarter ended
June 30, 2003

  Six-months ended June 30, 2003
Net income   $ 15.0   $ 25.8
   
 

Weighted average outstanding common shares

 

 

 

 

 

 
  Basic     40,057,077     40,003,210
  Effect of dilutive securities (stock options)     1,647,309     1,349,324
   
 
  Diluted     41,704,386     41,352,534
   
 

Basic net income per share

 

$

0.37

 

$

0.64
Diluted net income per share   $ 0.36   $ 0.62

        The Predecessor Company's computation of earnings per share was based on the "two-class" method described in SFAS No. 128, "Earnings Per Share." In computing earnings per share, (1) the current year yield on the Class L Common Stock is separately allocated to Class L shareholders (except in years the Company incurs a loss as Class L shareholders are not entitled to a return in such years) and, (2) income available to common shareholders (income less preferred stock dividends, less current year yield on Class L Common Stock) is allocated ratably between Class L Common Stock, Common Stock, and Class B Common Stock. Any Unreturned Original Cost plus Unpaid Yield are not components of the earnings per share computations.

        As of June 30, 2002, the Predecessor Company had the following common stock outstanding:

10


        The computations of basic and diluted income per share for the Predecessor Company are set forth in the following table (dollars in millions, except per share data).

 
  Quarter ended
June 30, 2002

  Six-months ended June 30, 2002
 
Loss before cumulative effect of change in accounting principle   $ (7.9 ) $ (12.3 )
Less preferred stock dividends     0.9     1.3  
   
 
 
Loss before cumulative effect of change in accounting principle available for common stock     (8.8 )   (13.6 )
Cumulative effect of change in accounting principle         20.0  
   
 
 
Net (loss) income available for common stock   $ (8.8 ) $ 6.4  
   
 
 
Basic and diluted weighted average outstanding common shares     49,702,512     49,702,512  
   
 
 
Basic and diluted (loss) income per Class L common share and Common share:              
  Loss before cumulative effect of change in accounting principle   $ (0.18 ) $ (0.27 )
  Cumulative effect of change in accounting principle         0.40  
   
 
 
  Net (loss) income available for common stock   $ (0.18 ) $ 0.13  
   
 
 

        Predecessor Company outstanding stock options at June 30, 2002 of 8.7 million, were not included because to do so would have been anti-dilutive.

Stock-Based Compensation

        SFAS No. 123, "Accounting for Stock-Based Compensation," encourages, but does not require, the use of a fair value method for recording compensation expense for stock-based compensation plans. The Company has elected to continue to account for its stock-based compensation plans using the intrinsic value method in accordance with Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees" ("APB No. 25") and related interpretations. Under the intrinsic value method, compensation expense for stock options is based on the excess, if any, of the fair value of the stock at the date of the grant over the amount the employee must pay to acquire the stock.

11



        The following table illustrates the effect on net income and income per share as if the fair value based method has been applied to all outstanding and unvested awards in each period. The fair value of the stock options was estimated using the Black-Scholes option pricing model.

 
  Quarter ended
June 30, 2003

  Quarter ended
June 30, 2002

 
 
  (in millions, except
per share data)

 
Net income (loss) available for common stock as reported   $ 15.0   $ (8.8 )
Add: Total stock-based employee compensation expense included in reported net income (loss), net of related tax effects     0.1     0.4  
Deduct: Total stock-based employee compensation expense determined under fair value based methods for all awards, net of related tax effects     (1.2 )   (0.7 )
   
 
 
Pro forma net income (loss)   $ 13.9   $ (9.1 )
   
 
 

Successor Company income per share:

 

 

 

 

 

 

 
  Basic as reported   $ 0.37        
  Basic pro forma   $ 0.34        
  Diluted as reported   $ 0.36        
  Diluted pro forma   $ 0.34        
Predecessor Company loss per share:              
  Basic and diluted loss per Class L common share and Common share as reported         $ (0.18 )
  Basic and diluted loss per Class L common share and Common share pro forma         $ (0.18 )
 
  Six-months ended
June 30, 2003

  Six-months ended June 30, 2002
 
 
  (in millions, except
per share data)

 
Net income available for common stock as reported   $ 25.8   $ 6.4  
Add: Total stock-based employee compensation expense included in reported net income, net of related tax effects     0.9     0.8  
Deduct: Total stock-based employee compensation expense determined under fair value based methods for all awards, net of related tax effects     (3.6 )   (1.4 )
   
 
 
Pro forma net income   $ 23.1   $ 5.8  
   
 
 
Successor Company income per share:              
  Basic as reported   $ 0.64        
  Basic pro forma   $ 0.58        
  Diluted as reported   $ 0.62        
  Diluted pro forma   $ 0.57        
Predecessor Company income per share:              
  Basic and diluted income per Class L common share and Common share as reported         $ 0.13  
  Basic and diluted income per Class L common share and Common share pro forma         $ 0.12  

12


        In May 2003, the Company's shareholders approved the Employee Stock Purchase Plan. Under this plan, employees may contribute 1% to 12% of their salary during an offering period (6 months) to purchase stock on the last day of the offering period. The stock is purchased at a discount of 15% of the lesser of the market price on the first or last day of the offering period. The Company has 1,000,000 authorized shares reserved for this plan; therefore, the Company does not intend to purchase the shares on the open market at the end of an offering period. This plan qualifies an an "employee stock purchase plan" under Section 423 of the Internal Revenue Code and has been determined to meet the noncompensatory plan requirements of APB No. 25. As such, no employee compensation expense has been recorded under this plan.

Change in Accounting Principle

        In June 2001, the Financial Accounting Standards Board ("FASB") issued SFAS No. 141, "Business Combinations" and SFAS No. 142 "Goodwill and Other Intangible Assets." SFAS No. 141 requires that all business combinations initiated after June 30, 2001, be accounted for using the purchase method of accounting. SFAS No. 141 also requires that the amount that the fair value of net assets exceeds the cost of the acquired entity, after the pro rata reduction of certain acquired assets ("negative goodwill") be recognized as a change in accounting principle upon adoption. As such, unamortized negative goodwill at December 31, 2001 aggregating $20.0 million was recognized as the cumulative effect of a change in accounting principle on January 1, 2002. With the adoption of SFAS No. 142 on January 1, 2002, goodwill and other intangible assets that have indefinite useful lives will no longer be subject to amortization, but rather, be tested at least annually for impairment. As of January 1, 2002, there was no material impact caused by the initial impairment assessment requirements of SFAS No. 142.

New Accounting Pronouncements

        FASB Interpretation No. 45, "Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others" ("FIN 45"), was issued in November 2002. The initial recognition and measurement provisions of this new standard, which require a guarantor to recognize a liability at inception of a guarantee at fair value, are effective on a prospective basis to guarantees issued or modified on or after January 1, 2003. The disclosure provisions, which increase the required disclosures relating to guarantees, were adopted in the Company's consolidated financial statements as of December 31, 2002. The adoption of FIN 45 did not have a material impact on the Company's consolidated financial statements.

        FASB Interpretation No. 46, "Consolidation of Variable Interest Entities" ("FIN 46"), was issued in January 2003. FIN 46 defines variable interest entities ("VIE") and requires that the assets, liabilities, non-controlling interests, and results of activities of a VIE be consolidated if certain conditions are met. For VIE's created on or before January 31, 2003, the guidance will be applied at the beginning of the third quarter of 2003. For VIE's created after that date, the guidance will be applied immediately; however, no VIE's have been created by the Company. The new rules may be applied prospectively with a cumulative-effect adjustment as of the beginning of the period in which it is first applied or by restating previously issued financial statements for one or more years with a cumulative-effect adjustment as of the beginning of the first year restated. As the Company does not have any VIE's, FIN 46 does not currently have an effect on the Company's consolidated financial statements.

13



        In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." SFAS No. 149 amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts and for hedging activities under SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities." SFAS No. 149 is effective for contracts entered into or modified after June 30, 2003, and for hedging relationships designated after that date. The provisions of SFAS No. 149 should be applied prospectively. The Company is in the process of evaluating the potential effect of this recently issued accounting pronouncement on the Company's future consolidated financial statements.

3.    Inventories

        Inventories are stated at the lower of cost (first-in, first-out method) or market. Cost includes materials, labor and manufacturing overhead costs. Market for raw materials is based on replacement costs and, for other inventory classifications, on net realizable value. Appropriate consideration is given to deterioration, obsolescence and other factors in evaluating net realizable value. Inventories consist of the following (in millions):

 
  June 30, 2003
  December 31, 2002
Raw materials   $ 28.9   $ 27.9
Work-in-process     40.8     36.2
Finished products     108.9     110.2
   
 
  Total inventories   $ 178.6   $ 174.3
   
 

4.    Identifiable Intangible Assets

        Identifiable intangible assets are being amortized over their legal or estimated useful lives, whichever is shorter (generally not exceeding 17 years), except for trade names and trademarks, which are not subject to amortization since they have an indefinite life. Identifiable intangible assets include the following at June 30, 2003 and December 31, 2002 (in millions):

 
  June 30, 2003
  December 31, 2002
 
  Gross
Amount

  Accumulated
Amortization

  Net Amount
  Gross Amount
  Accumulated
Amortization

  Net Amount
Tradenames and trademarks   $ 135.0     N/A   $ 135.0   $ 135.0     N/A   $ 135.0
Customer relationships     125.9   $ (9.8 )   116.1     122.4   $ (3.0 )   119.4
Developed technology     126.5     (13.9 )   112.6     120.6     (4.3 )   116.3
Internally developed software     35.7     (2.9 )   32.8     31.2     (0.9 )   30.3
Patents     15.6     (1.4 )   14.2     13.7     (0.4 )   13.3
   
 
 
 
 
 
    $ 438.7   $ (28.0 ) $ 410.7   $ 422.9   $ (8.6 ) $ 414.3
   
 
 
 
 
 

        Amortization expense totaled $9.3 million and $4.5 million for the quarters ended June 30, 2003 and 2002, respectively, and $18.9 million and $8.0 million for the six-months ended June 30, 2003 and 2002, respectively. The estimated amount of annual amortization expense for the identifiable intangible assets (based on currently existing intangible assets, which are significantly different from those as of June 30, 2002 due to the application of fresh-start reporting) during the period from 2003 through 2007 is $37.2 million.

14


5.    Restructuring Reserves

        In 1997, in connection with the acquisition of Behring Diagnostics from Aventis S.A., the Company allocated $74.3 million of the purchase price for a restructuring plan to consolidate manufacturing and distribution operations and to eliminate redundant sales, service and administrative functions (the "1997 Behring Allocation Reserve"). The remaining activities associated with this reserve are expected to be substantially completed in the fourth quarter of 2003 when the Company is required to make a $1.5 million payment related to a facility no longer being utilized.

        In June 2000, the Company reviewed its cost structure and announced a global cost reduction program. The Company eliminated a number of redundant positions under this program in 2000 and 2001, which affected certain employees in virtually all functions throughout the Company, while adding staff in key areas, such as the direct distribution centers. The anticipated net effect of these changes was a reduction of approximately 450 positions. Of the net 450 position reductions, 242 employees were severed in 2000 and 193 employees were severed in 2001. Additionally, one domestic distribution center and various international sales offices were closed, all of which were leased. Management approved and initiated several actions contemplated by the cost reduction program and recorded a pre-tax reserve of $32.5 million as of December 31, 2000 (the "2000 Reserve"). The charge included $29.3 million for severance and $3.2 million primarily for losses on leases. During 2001, an additional $3.3 million for severance and $6.5 million for facility and other exit costs, primarily as a result of not closing a subletting transaction contemplated in the Company's original restructuring plan, was provided. Separately, also during 2001, excess severance accruals of $4.9 million were identified and credited to income. This was primarily due to a higher than expected number of employees either voluntarily terminating prior to being eligible for severance payments or electing to transfer to other Company locations. The balance in this reserve at December 31, 2001 was $10.9 million. A credit to income of $5.9 million during the period ended October 1, 2002 was recorded primarily due to negotiations that resulted in a reduction of the estimated loss on leases as well as the reversal of excess severance accruals due to higher than expected number of employees either voluntarily terminating prior to being eligible for severance payments or electing to transfer to other Company locations. The majority of actions contemplated in this reserve were completed during 2002.

        In November 2001, management approved additional cost reduction programs with the stated objective of further reducing the Company's cost structure. This cost reduction program is an extension of the cost reduction program approved in 2000 and impacted many functions throughout the Company. The Company eliminated 73 positions in 2001. Additionally, the Company consolidated certain facilities which resulted in incurring losses on leases at two domestic offices. Pursuant to these programs described above, management approved a pre-tax reserve of $7.2 million (the "2001 Reserve"). This charge included $4.3 million for severance and $2.9 million primarily for losses on leases. The majority of actions contemplated by these actions were completed during 2002. During 2002, due to the continuation of restructuring activities initiated in November 2001, 70 additional positions were eliminated across numerous functions of the Company at international locations. This resulted in an additional charge of $2.9 million.

15



        The following tables summarize the Company's restructuring activity for the period ended June 30, 2003 (in millions):

 
  Facility and Other Exit Costs
  Severance and Relocation
  Total
 
1997 Behring Allocation Reserve                    
Reserve balance, December 31, 2002   $ 1.5   $ 0.4   $ 1.9  
  Cash payments         (0.1 )   (0.1 )
   
 
 
 
Reserve balance, June 30, 2003   $ 1.5   $ 0.3   $ 1.8  
   
 
 
 
 
  Facility and Other Exit Costs
  Severance
  Total
 
2000 Reserve                    
Reserve balance, December 31, 2002   $ 0.3   $ 0.7   $ 1.0  
  Cash payments         (0.2 )   (0.2 )
   
 
 
 
Reserve balance, June 30, 2003   $ 0.3   $ 0.5   $ 0.8  
   
 
 
 
 
  Facility and Other Exit Costs
  Severance
  Total
 
2001 Reserve                    
Reserve balance, December 31, 2002   $ 1.0   $ 1.2   $ 2.2  
  Cash payments     (0.1 )   (0.6 )   (0.7 )
   
 
 
 
Reserve balance, June 30, 2003   $ 0.9   $ 0.6   $ 1.5  
   
 
 
 

16


6.    Business Segment and Geographic Information

        The Company derives substantially all its revenues from manufacturing and marketing IVD products and services. The Company is organized functionally and is comprised of three reporting segments: Global Customer Management ("GCM")-North America, GCM-International, and Global Operations. GCM-North America and GCM-International are the Company's sales and service organizations. For the Company's reporting purposes, North America includes the United States and Canada. The United States comprises over ninety percent of the North America segment's results. International includes sales and service results from all other countries. Global Operations primarily includes all manufacturing and research and development activities, which occur in the United States and Germany, and accordingly does not recognize significant revenues.

        Earnings before interest and income taxes ("EBIT") is a primary profitability measure used to evaluate the segments. Financial information by segment for the six-months and quarters ended June 30, 2003 and 2002 is summarized as follows (in millions):

 
  GCM-North
America

  GCM-International
  Global
Operations

  All Other(1)
  Total
Quarter ended June 30, 2003                              
  Revenue from external customers:                              
  Core Chemistry   $ 124.5   $ 106.1   $   $   $ 230.6
  Hemostasis     23.1     36.2             59.3
  Microbiology     20.1     15.3             35.4
  Infectious Disease     0.3     19.6             19.9
  Mature Products     6.5     7.4     2.6         16.5
   
 
 
 
 
  Total   $ 174.5   $ 184.6   $ 2.6   $   $ 361.7
   
 
 
 
 
  Depreciation and amortization     5.1     13.8     11.8     2.9     33.6
  Segment EBIT     68.7     59.8     (61.1 )   (24.6 )   42.8
Quarter ended June 30, 2002                              
  Revenue from external customers:                              
  Core Chemistry   $ 111.8   $ 85.0   $   $   $ 196.8
  Hemostasis     22.9     28.7             51.6
  Microbiology     19.1     13.4             32.5
  Infectious Disease     0.4     17.6             18.0
  Mature Products     7.6     10.4     1.1         19.1
   
 
 
 
 
  Total   $ 161.8   $ 155.1   $ 1.1   $   $ 318.0
   
 
 
 
 
  Depreciation and amortization     2.9     13.7     8.0     4.5     29.1
  Segment EBIT     63.4     43.7     (54.7 )   (27.0 )   25.4

17


 
  GCM-North
America

  GCM-International
  Global
Operations

  All Other(1)
  Total
Six-months ended June 30, 2003                              
  Revenue from external customers:                              
  Core Chemistry   $ 243.5   $ 202.9   $   $   $ 446.4
  Hemostasis     45.5     71.1             116.6
  Microbiology     39.1     28.4             67.5
  Infectious Disease     0.5     38.5             39.0
  Mature Products     12.8     17.1     5.0         34.9
   
 
 
 
 
  Total   $ 341.4   $ 358.0   $ 5.0   $   $ 704.4
   
 
 
 
 
  Depreciation and amortization     10.0     27.0     23.4     5.4     65.8
  Segment EBIT     131.8     114.8     (117.2 )   (50.0 )   79.4
Six-months ended June 30, 2002                              
  Revenue from external customers:                              
  Core Chemistry   $ 228.5   $ 161.0   $   $   $ 389.5
  Hemostasis     42.8     58.0             100.8
  Microbiology     36.0     25.0             61.0
  Infectious Disease     0.5     32.9             33.4
  Mature Products     16.3     21.0     2.2         39.5
   
 
 
 
 
  Total   $ 324.1   $ 297.9   $ 2.2   $   $ 624.2
   
 
 
 
 
  Depreciation and amortization     5.7     26.6     15.7     8.0     56.0
  Segment EBIT     125.3     83.8     (104.1 )   (53.5 )   51.5

(1)
Includes corporate headquarters, shared services centers, restructuring expense, certain other expenses such as income taxes, general corporate expenses, certain intercompany transactions and eliminations, as well as for the Predecessor Company the effects of purchase accounting which have not been reflected in segment accounting records. Consequently, asset write-downs resulting from bargain purchases are reflected in the All Other column.

18


        A reconciliation of segment EBIT to income (loss) before income tax and cumulative effect of change in accounting principle for the quarters and six-months ended June 30, 2003 and 2002 is summarized as follows (in millions):

 
  Quarter ended June 30, 2003
  Quarter ended June 30, 2002
 
Reconciliation of Segment EBIT to Income (loss) before income tax and cumulative effect of change in accounting principle              
  Total Segment EBIT   $ 42.8   $ 25.4  
  Less: Interest expense, net     (19.6 )   (31.4 )
   
 
 
  Income (loss) before income tax and cumulative effect of change in accounting principle   $ 23.2   $ (6.0 )
   
 
 
 
  Six-months ended June 30, 2003
  Six-months ended June 30, 2002
 
Reconciliation of Segment EBIT to Income (loss) before income tax and cumulative effect of change in accounting principle              
  Total Segment EBIT   $ 79.4   $ 51.5  
  Less: Interest expense, net     (38.6 )   (61.2 )
   
 
 
  Income (loss) before income tax and cumulative effect of change in accounting principle   $ 40.8   $ (9.7 )
   
 
 

        Goodwill at December 31, 2002 aggregated $543.0 million. The amount of goodwill allocated to each segment at December 31, 2002 was $271.5 million for Global Operations, $135.8 for Global Customer Management-North America, and $135.7 million for Global Customer Management-International. Goodwill at June 30, 2003 aggregated $524.7 million. The amount of goodwill allocated to each segment at June 30, 2003 was $264.6 million for Global Operations, $128.9 for Global Customer Management-North America, and $131.2 million for Global Customer Management-International. The change in goodwill balances during the first six months of 2003 are due to reductions in deferred tax asset valuation allowances that existed at the date fresh-start reporting was applied. Per SOP 90-7, the reductions were credited first to goodwill.

7.    Guarantor/Non-Guarantor Financial Statements

        In connection with DBI's issuance of 11.91% senior subordinated notes, Dade Behring Holdings, Inc. and certain of DBI's U.S. subsidiaries became guarantors of these notes. The following tables present condensed consolidating financial information for the guarantors, non-guarantors, DBI, and Dade Behring Holdings, Inc. Other than Dade Behring Holdings, Inc., each of the guarantors is a direct or indirect wholly owned subsidiary of DBI. The guarantors fully, jointly and severally unconditionally guarantee these notes. The following unaudited condensed consolidating financial information presents the results of operations, financial position and cash flows and the eliminations necessary to arrive at the information for DBI on a condensed consolidated basis. All amounts are in millions.

19




Successor Company Condensed Consolidating Balance Sheet
June 30, 2003

 
  DBHI
  DBI
  Other
Guarantors

  Non-
Guarantors

  Eliminations
  Total
Assets                                    
Current assets:                                    
  Cash and cash equivalents   $   $ 53.6   $ 0.3   $ 23.8   $   $ 77.7
  Restricted cash                 8.7         8.7
  Accounts receivable, net         76.4     12.2     195.2         283.8
  Inventories         69.7     25.2     105.8     (22.1 )   178.6
  Prepaid expenses         2.5     1.9     10.4         14.8
  Deferred income taxes                 0.9         0.9
   
 
 
 
 
 
Total current assets         202.2     39.6     344.8     (22.1 )   564.5
Property, plant and equipment, net         147.4     37.3     220.3     (7.1 )   397.9
Debt issuance costs, net         12.7                 12.7
Goodwill, net         524.7                 524.7
Deferred income taxes                 7.5         7.5
Identifiable intangible assets, net         281.1     13.2     133.6     (17.2 )   410.7
Other assets     (0.4 )   16.5     2.1     11.6         29.8
Intercompany receivables     467.8     878.3     458.1     6.7     (1,810.9 )  
Investments in affiliates     622.2     481.3             (1,103.5 )  
   
 
 
 
 
 
Total assets   $ 1,089.6   $ 2,544.2   $ 550.3   $ 724.5   $ (2,960.8 ) $ 1,947.8
   
 
 
 
 
 
Liabilities and Shareholders' Equity                                    
Current liabilities:                                    
  Short-term debt   $   $   $   $ 3.3   $   $ 3.3
  Accounts payable         29.3     7.1     38.4         74.8
  Accrued liabilities         96.9     10.3     115.6         222.8
   
 
 
 
 
 
Total current liabilities         126.2     17.4     157.3         300.9
  Long-term debt         747.3                 747.3
  Deferred income taxes         62.0     0.4     58.3         120.7
  Other liabilities         66.9     0.1     81.7         148.7
  Intercompany payables     459.4     919.6     218.5     213.4     (1,810.9 )  
   
 
 
 
 
 
Total liabilities     459.4     1,922.0     236.4     510.7     (1,810.9 )   1,317.6
Total shareholders' equity     630.2     622.2     313.9     213.8     (1,149.9 )   630.2
   
 
 
 
 
 
Total liabilities and shareholders' equity   $ 1,089.6   $ 2,544.2   $ 550.3   $ 724.5   $ (2,960.8 ) $ 1,947.8
   
 
 
 
 
 

20



Successor Company Condensed Consolidating Balance Sheet
December 31, 2002

 
  DBHI
  DBI
  Other Guarantors
  Non-
Guarantors

  Eliminations
  Total
Assets                                    
Current assets:                                    
  Cash and cash equivalents   $   $ 16.3   $   $ 19.2   $   $ 35.5
  Restricted cash                 7.9         7.9
  Accounts receivable, net         78.5     13.9     197.3         289.7
  Inventories         70.9     24.2     95.3     (16.1 )   174.3
  Prepaid expenses         9.8     0.7     8.4         18.9
  Deferred income taxes                 0.4         0.4
   
 
 
 
 
 
Total current assets         175.5     38.8     328.5     (16.1 )   526.7
Property, plant and equipment, net         151.4     39.6     204.0     (4.5 )   390.5
Debt issuance costs, net         14.0                 14.0
Goodwill, net         543.0                 543.0
Deferred income taxes                 3.5         3.5
Identifiable intangible assets, net         287.7     13.0     130.5     (16.9 )   414.3
Other assets         16.9     1.8     8.1         26.8
Intercompany receivables     459.6     926.8     450.1     183.4     (2,019.9 )  
Investments in affiliates     587.8     424.8             (1,012.6 )  
   
 
 
 
 
 
Total assets   $ 1,047.4   $ 2,540.1   $ 543.3   $ 858.0   $ (3,070.0 ) $ 1,918.8
   
 
 
 
 
 

Liabilities and Shareholders' Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Current liabilities:                                    
  Short-term debt   $   $   $   $ 6.1   $   $ 6.1
  Current portion of long-term debt         5.0                 5.0
  Accounts payable         29.7     6.2     40.9         76.8
  Accrued liabilities         123.2     8.8     96.5         228.5
   
 
 
 
 
 
Total current liabilities         157.9     15.0     143.5         316.4
  Long-term debt         760.7                 760.7
  Deferred income taxes         62.4         60.2         122.6
  Other liabilities         58.8     0.1     72.1         131.0
  Intercompany payables     459.3     912.5     110.5     537.6     (2,019.9 )  
   
 
 
 
 
 
Total liabilities     459.3     1,952.3     125.6     813.4     (2,019.9 )   1,330.7
Total shareholders' equity     588.1     587.8     417.7     44.6     (1,050.1 )   588.1
   
 
 
 
 
 
Total liabilities and shareholders' equity   $ 1,047.4   $ 2,540.1   $ 543.3   $ 858.0   $ (3,070.0 ) $ 1,918.8
   
 
 
 
 
 

21



Successor Company Condensed Consolidating Statement of Operations
Quarter Ended June 30, 2003

 
  DBHI
  DBI
  Other Guarantors
  Non-
Guarantors

  Eliminations
  Total
 
Net sales   $   $ 181.2   $ 55.1   $ 193.7   $ (68.3 ) $ 361.7  
Cost of goods sold         97.1     28.8     107.3     (64.0 )   169.2  
   
 
 
 
 
 
 
Gross profit         84.1     26.3     86.4     (4.3 )   192.5  
Operating costs and expenses:                                      
  Marketing and administrative expenses         60.6     3.0     57.4         121.0  
  Research and development expenses         16.3     2.4     11.8         30.5  
   
 
 
 
 
 
 
Income from operations         7.2     20.9     17.2     (4.3 )   41.0  
Other (expense) income:                                      
  Interest expense         (17.7 )       (5.1 )   2.3     (20.5 )
  Interest income         2.5         0.7     (2.3 )   0.9  
  Other, primarily intercompany charges         29.7     (26.5 )   (0.8 )   (0.6 )   1.8  
   
 
 
 
 
 
 
Income (loss) before income tax         21.7     (5.6 )   12.0     (4.9 )   23.2  
Income tax (benefit) expense         (0.9 )       1.7     7.4     8.2  
   
 
 
 
 
 
 
Income (loss) before equity in earnings of unconsolidated subsidiaries         22.6     (5.6 )   10.3     (12.3 )   15.0  
Equity in earnings of unconsolidated subsidiaries     15.0     (7.6 )           (7.4 )    
   
 
 
 
 
 
 
Net income (loss)   $ 15.0   $ 15.0   $ (5.6 ) $ 10.3   $ (19.7 ) $ 15.0  
   
 
 
 
 
 
 


Successor Company Condensed Consolidating Statement of Operations
Six-months Ended June 30, 2003

 
  DBHI
  DBI
  Other Guarantors
  Non-
Guarantors

  Eliminations
  Total
 
Net sales   $   $ 354.6   $ 109.2   $ 378.1   $ (137.5 ) $ 704.4  
Cost of goods sold         191.8     58.3     211.7     (128.7 )   333.1  
   
 
 
 
 
 
 
Gross profit         162.8     50.9     166.4     (8.8 )   371.3  
Operating costs and expenses:                                      
  Marketing and administrative expenses         117.2     5.6     111.8         234.6  
  Research and development expenses         29.3     4.8     22.2         56.3  
   
 
 
 
 
 
 
Income from operations         16.3     40.5     32.4     (8.8 )   80.4  
Other (expense) income:                                      
  Interest expense         (35.6 )       (9.7 )   4.9     (40.4 )
  Interest income         5.1     0.1     1.5     (4.9 )   1.8  
  Other, primarily intercompany charges         36.3     (26.8 )   (10.6 )   0.1     (1.0 )
   
 
 
 
 
 
 
Income before income tax         22.1     13.8     13.6     (8.7 )   40.8  
Income tax expense (benefit)         (0.9 )       2.3     13.6     15.0  
   
 
 
 
 
 
 
Income before equity in earnings of unconsolidated subsidiaries         23.0     13.8     11.3     (22.3 )   25.8  
Equity in earnings of unconsolidated subsidiaries     25.8     2.8             (28.6 )    
   
 
 
 
 
 
 
Net income   $ 25.8   $ 25.8   $ 13.8   $ 11.3   $ (50.9 ) $ 25.8  
   
 
 
 
 
 
 

22



Predecessor Company Condensed Consolidating Statement of Operations
Quarter Ended June 30, 2002

 
  DBHI
  DBI
  Other Guarantors
  Non-
Guarantors

  Eliminations
  Total
 
Net sales   $   $ 166.1   $ 47.6   $ 155.0   $ (50.7 ) $ 318.0  
Cost of goods sold         94.7     26.8     82.9     (47.9 )   156.5  
   
 
 
 
 
 
 
Gross profit         71.4     20.8     72.1     (2.8 )   161.5  
Operating costs and expenses:                                      
  Marketing and administrative expenses         58.2     3.3     46.6         108.1  
  Research and development expenses         12.8     2.3     7.3         22.4  
  Cost reduction programs expense         0.2         0.7         0.9  
  Restructuring expense, net         (0.5 )               (0.5 )
   
 
 
 
 
 
 
Income from operations         0.7     15.2     17.5     (2.8 )   30.6  
Other (expense) income:                                      
  Interest expense         (28.8 )       (5.4 )   2.0     (32.2 )
  Interest income         1.6         1.2     (2.0 )   0.8  
  Balance sheet restructuring costs         (8.7 )               (8.7 )
  Other, primarily intercompany charges         9.8     (0.3 )   (4.5 )   (1.5 )   3.5  
   
 
 
 
 
 
 
Income (loss) before income tax         (25.4 )   14.9     8.8     (4.3 )   (6.0 )
Income tax expense         0.1         2.0     (0.2 )   1.9  
   
 
 
 
 
 
 
Income (loss) before equity in earnings of unconsolidated subsidiaries           (25.5 )   14.9     6.8     (4.1 )   (7.9 )
Equity in earnings of unconsolidated subsidiaries     (7.9 )   17.6             (9.7 )    
   
 
 
 
 
 
 
Net income (loss)   $ (7.9 ) $ (7.9 ) $ 14.9   $ 6.8   $ (13.8 ) $ (7.9 )
   
 
 
 
 
 
 


Predecessor Company Condensed Consolidating Statement of Operations
Six-months Ended June 30, 2002

 
  DBHI
  DBI
  Other Guarantors
  Non-
Guarantors

  Eliminations
  Total
 
Net sales   $   $ 327.4   $ 97.2   $ 296.1   $ (96.5 ) $ 624.2  
Cost of goods sold         188.8     50.0     156.2     (90.3 )   304.7  
   
 
 
 
 
 
 
Gross profit         138.6     47.2     139.9     (6.2 )   319.5  
Operating costs and expenses:                                      
  Marketing and administrative expenses         110.2     6.6     90.3         207.1  
  Research and development expenses         25.7     4.0     11.5         41.2  
  Cost reduction programs expense         0.4     0.1     1.4         1.9  
  Restructuring expense, net         1.8         (0.4 )       1.4  
   
 
 
 
 
 
 
Income from operations         0.5     36.5     37.1     (6.2 )   67.9  
Other (expense) income:                                      
  Interest expense         (54.6 )       (11.6 )   3.3     (62.9 )
  Interest income         3.0     0.1     1.9     (3.3 )   1.7  
  Balance sheet restructuring costs         (12.5 )               (12.5 )
  Other, primarily intercompany charges         30.6     (1.4 )   (32.2 )   (0.9 )   (3.9 )
   
 
 
 
 
 
 
Income (loss) before income tax         (33.0 )   35.2     (4.8 )   (7.1 )   (9.7 )
Income tax expense         0.1         2.7     (0.2 )   2.6  
   
 
 
 
 
 
 
Income before cumulative effect of change in accounting principle and equity in earnings of unconsolidated subsidiaries         (33.1 )   35.2     (7.5 )   (6.9 )   (12.3 )
Equity in earnings of unconsolidated subsidiaries     7.7     20.8             (28.5 )    
Cumulative effect of change in accounting principle         20.0                 20.0  
   
 
 
 
 
 
 
Net income (loss)   $ 7.7   $ 7.7   $ 35.2   $ (7.5 ) $ (35.4 ) $ 7.7  
   
 
 
 
 
 
 

23



Successor Company Condensed Consolidating Statement of Cash Flows
Six-months Ended June 30, 2003

 
  DBHI
  DBI
  Other Guarantors
  Non-
Guarantors

  Eliminations
  Total
 
Operating Activities:                                      
Net income   $ 25.8   $ 25.8   $ 13.8   $ 11.3   $ (50.9 ) $ 25.8  
Adjustments to reconcile net income to net cash provided by (utilized for) operating activities:                                      
  Equity in earnings of unconsolidated subsidiaries     (25.8 )   (2.8 )           28.6      
  Depreciation and amortization expense         24.5     5.5     37.5     (1.7 )   65.8  
  Net loss on disposal of fixed assets         0.5     0.2     0.9         1.6  
  Stock-based compensation expense         1.5                 1.5  
  Deferred income taxes                 10.0         10.0  
  Changes in balance sheet items:                                      
    Accounts receivable, net         2.1     1.7     16.4         20.2  
    Inventories         1.2     (1.0 )   2.6         2.8  
    Prepaid expenses         7.3     (1.2 )   (1.5 )       4.6  
    Accounts payable         (0.4 )   0.9     (5.4 )       (4.9 )
    Accrued liabilities         (26.3 )   1.5     2.9         (21.9 )
    Other, net     (1.1 )   36.5     (17.3 )   (40.1 )   24.0     2.0  
   
 
 
 
 
 
 
Net cash flow provided by (utilized for) operating activities     (1.1 )   69.9     4.1     34.6         107.5  
   
 
 
 
 
 
 

Investing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Capital expenditures         (12.6 )   (3.8 )   (28.9 )       (45.3 )
   
 
 
 
 
 
 
Net cash flow utilized for investing activities         (12.6 )   (3.8 )   (28.9 )       (45.3 )
   
 
 
 
 
 
 

Financing Activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Increase in restricted cash                 (0.1 )       (0.1 )
Net repayments related to short-term debt                 (2.9 )       (2.9 )
Repayments of borrowings under new bank credit facility         (20.0 )               (20.0 )
Proceeds from exercise of stock options     1.1                     1.1  
   
 
 
 
 
 
 
Net cash flow (utilized for) provided by financing activities     1.1     (20.0 )       (3.0 )       (21.9 )
   
 
 
 
 
 
 
Effect of foreign exchange rates on cash                 1.9         1.9  
Net increase in cash and cash equivalents         37.3     0.3     4.6         42.2  

Cash and Cash Equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Beginning of Period         16.3         19.2         35.5  
   
 
 
 
 
 
 
End of Period   $   $ 53.6   $ 0.3   $ 23.8   $   $ 77.7  
   
 
 
 
 
 
 

24



Predecessor Company Condensed Consolidating Statement of Cash Flows
Six-months Ended June 30, 2002

 
  DBHI
  DBI
  Other Guarantors
  Non-
Guarantors

  Eliminations
  Total
 
Operating Activities:                                      
Net income (loss)   $ 7.7   $ 7.7   $ 35.2   $ (7.5 ) $ (35.4 ) $ 7.7  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:                                      
  Equity in earnings of unconsolidated subsidiaries     (7.7 )   (20.8 )           28.5      
  Cumulative effect of change in accounting principle         (20.0 )               (20.0 )
  Depreciation and amortization expense         23.8     5.5     26.7         56.0  
  Net loss on disposal of fixed assets         1.2     1.2     1.4         3.8  
  Stock-based compensation expense         0.8                 0.8  
  Deferred income taxes                 0.1         0.1  
  Changes in balance sheet items:                                      
    Accounts receivable, net     (0.3 )   (1.1 )   10.9     (32.4 )       (22.9 )
    Inventories         1.1     4.5     2.8         8.4  
    Prepaid expenses         0.7     0.4     (0.8 )       0.3  
    Accounts payable         (8.4 )       (10.3 )       (18.7 )
    Accrued liabilities         3.8     (1.0 )   1.7         4.5  
    Other, net     0.3     16.7     (53.2 )   41.5     6.9     12.2  
   
 
 
 
 
 
 
Net cash flow provided by operating activities         5.5     3.5     23.2         32.2  
   
 
 
 
 
 
 
Investing Activities:                                      
Capital expenditures         (11.9 )   (3.9 )   (22.5 )       (38.3 )
   
 
 
 
 
 
 
Net cash flow utilized for investing activities           (11.9 )   (3.9 )   (22.5 )       (38.3 )
   
 
 
 
 
 
 
Financing Activities:                                      
Decrease in restricted cash                 1.8         1.8  
Net repayments related to short-term debt                 (4.3 )       (4.3 )
Repayments of borrowings related to former revolving credit facility         (4.5 )       (1.7 )       (6.2 )
Repayments of borrowings related to former bank credit agreement         (17.5 )               (17.5 )
   
 
 
 
 
 
 
Net cash flow utilized for financing activities           (22.0 )         (4.2 )         (26.2 )
   
 
 
 
 
 
 
Effect of foreign exchange rates on cash                     1.9         1.9  
Net decrease in cash and cash equivalents         (28.4 )   (0.4 )   (1.6 )       (30.4 )
Cash and Cash Equivalents:                                    
Beginning of Period         67.8     0.4     18.6         86.8  
   
 
 
 
 
 
 
End of Period   $   $ 39.4   $   $ 17.0   $   $ 56.4  
   
 
 
 
 
 
 

25



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

        The Company's 2002 Annual Report on Form 10-K contains management's discussion and analysis of the Company's financial condition and results of operations as of and for the year ended December 31, 2002. The following management's discussion and analysis focuses on material changes since that time and should be read in conjunction with the 2002 Annual Report on Form 10-K. Relevant trends that are reasonably likely to be of a material nature are discussed to the extent known.

        Certain statements included in this discussion are forward-looking, such as statements relating to estimates of operating and capital expenditure requirements, future revenue and operating income levels, cash flow and liquidity. Such forward-looking statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results in the future to differ significantly from results expressed or implied in any forward-looking statements made by, or on behalf of, the Company. These risks and uncertainties include, but are not limited to, uncertainties relating to global economic and business conditions, governmental and regulatory policies such as healthcare reimbursement policies, and the competitive environment in which the Company operates. These and other risks are discussed in some detail below as well as in our registration statement on Form S-1 dated April 11, 2003 filed by the Company with the Securities and Exchange Commission.

Results of Operations

        We derive substantially all our revenue from manufacturing and marketing IVD products and services. We are organized functionally and have three reporting segments: Global Customer Management ("GCM")-North America, GCM-International and Global Operations. GCM-North America and GCM-International are our sales and service organizations. For our reporting purposes, North America includes the United States and Canada. International includes sales and service results from all other countries. The gross profit margin for the two GCM segments are not materially different. Global Operations primarily includes all manufacturing and research and development activities, and accordingly does not recognize significant revenues. Global Operations functions as a cost center; consequently a discussion of gross profit for each individual operating segment would not be meaningful. Generally, Global Operations does not incur a material amount of our marketing and administrative expense, but is responsible for virtually all research and development expense. Restructuring charges and certain other expenses, such as income taxes, general corporate expenses and financing costs, are not allocated to the operating segments.

Bankruptcy Proceedings

        Greater detail of the following discussion can be found in our 2002 Annual Report on Form 10-K.

        On August 1, 2002, Dade Behring Holdings, Inc. and certain of its wholly-owned direct and indirect domestic subsidiaries: Dade Behring Inc., Dade MicroScan Inc., Dade Finance, Inc., Syva Diagnostics Holding Co., Syva Childcare Inc., Syva Company, and Chimera Research & Chemical, Inc. filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code, as amended, with the United States Bankruptcy Court for the Northern District of Illinois. We collectively refer to the companies party to the bankruptcy proceedings as the "Debtors." On August 1, 2002, the Debtors filed their Disclosure Statement for their Joint Chapter 11 Plan of Reorganization, which we call the Plan of Reorganization. No other subsidiaries of Dade Behring Holdings, Inc. filed for relief under the United States Bankruptcy Code.

        The Bankruptcy Court confirmed the Plan of Reorganization on September 18, 2002 and the Plan became effective on October 3, 2002. The Plan of Reorganization allowed the Debtors to emerge from bankruptcy with an improved capital structure and, because the Debtors were allowed to continue

26



paying their trade debt on a timely basis during the pendency of the Chapter 11 cases, they had sufficient trade credit to continue their operations in the ordinary course of business. On the effective date of the Plan of Reorganization, Dade Behring Inc. entered into new credit facilities. See "Liquidity and Capital Resources—Credit Facilities" below for further discussion.

        As a result of the Plan of Reorganization, significant changes resulted to our capital structure. Although the Plan of Reorganization became effective on October 3, 2002, for financial reporting convenience purposes, we recorded the adjustments necessitated by SOP 90-7 on October 1, 2002. As a result of our emergence from Chapter 11 bankruptcy and the application of fresh-start reporting, our consolidated financial statements for the periods commencing on October 2, 2002 are referred to as the "Successor Company" and are not comparable with any periods prior to October 1, 2002, which are referred to as the "Predecessor Company." The effects of fresh-start reporting and new accounting pronouncements have materially changed the amounts previously recorded in our Predecessor Company's consolidated financial statements. All references to periods ended June 30, 2002 are to the Predecessor Company. All references to periods ended June 30, 2003 are to the Successor Company.

        The Plan of Reorganization and associated new senior credit agreement and capital structure provided for the following:

        Additionally, as part of the Plan of Reorganization, all equity instruments existing prior to our filing for bankruptcy were cancelled and new equity was issued. Approximately 99% of the new equity was issued to creditors who were not previously equity holders.

Successor Company Quarter Ended June 30, 2003 Compared to Predecessor Company Quarter Ended June 30, 2002

        In order to provide a meaningful basis of comparing the quarters ended June 30, 2003 and 2002, for purposes of the following discussion, the operating results of the Successor Company for the quarter ended June 30, 2003 are compared to the Predecessor Company for the quarter ended June 30, 2002. Changes to our capital structure and the adoption of fresh-start reporting primarily affects depreciation, amortization and interest expenses.

        In the discussion below, we make comparisons on a "constant currency" basis, which is not a U.S. GAAP defined measure. We believe this measure provides for a meaningful analysis of the underlying

27



activity, since it eliminates the effect of changes in foreign currency exchange rates. When making comparisons on a constant currency basis, we have calculated the change by comparing the applicable reported current year amount to the corresponding amount from the prior year in local currency translated at the foreign currency exchange rates for the current year. "Constant currency" as defined or presented by us may not be comparable to similarly titled measures reported by other companies.

        Net Sales.    Net sales for the quarter ended June 30, 2003 totaled $361.7 million as compared to $318.0 million in the corresponding prior year quarter.

        Sales for each segment were as follows (in millions):

 
  Quarter Ended
   
 
 
  June 30, 2003
  June 30, 2002
  % Change
 
GCM-North America   $ 174.5   $ 161.8   7.8 %
GCM-International     184.6     155.1   19.0 %
Global Operations     2.6     1.1   136.4 %
   
 
 
 
Total   $ 361.7   $ 318.0   13.7 %
   
 
     

        Adjusting for favorable impact of foreign currency rate changes of $26.4 million, 2003 sales increased $17.3 million or 5.0% for the quarter. On a constant currency basis, sales increased $12.1 million or 7.5% in GCM-North America, and $3.9 million or 2.2% across GCM-International locations. The increase on a constant currency basis can be attributed in part to a $19.9 million or 9.4% increase in core chemistry sales primarily driven by Dimension® product sales globally. During the quarter, the successful launch of the Dimension® RxL Max and higher placements of Dimension® Xpand™ contributed to the growth. The growth can also be attributed to a $1.8 million or 3.1% increase in hemostasis product sales with the strongest growth at international locations, a $1.7 million or 5.0% increase in microbiology product sales, offset by a $1.4 million or 6.8% decrease in infectious disease product sales and a $4.7 million or 22.0% decrease in sales of mature products across all segments. We define mature products as those products and services that we do not consider to be part of our core strategy and as a result, they are expected to have declining sales over time.

        The installed base of instruments placed with customers grew approximately 1.0% compared to the installed base at March 31, 2003. Growth in the instrument installed base of a product line contributes to the sales growth of the corresponding reagents, consumables and service. Growth in the installed base of instruments for Dimension® RxL, RxLMax™, and Xpand™ has driven much of the sales growth seen in our Dimension® products. Gains in the Hemostasis installed base have been driven by successes in CA-1500, CA-500, and PFA-100 instrument placements. For Microbiology, new installations of our AutoScan® and Walkaway® series of instruments continue to drive growth while the BEP®III and BEP 2000 instruments have been the primary contributors of installed base growth for the Infectious Disease product line. Improved method penetration, which results from utilizing an existing instrument base for additional tests, combined with the growth in higher priced, specialty reagents, have further contributed to our sales growth.

        Gross Profit.    Gross profit for the quarter ended June 30, 2003 increased $31.0 million to $192.5 million as compared to $161.5 million in the corresponding prior year period. On a constant currency basis gross profit increased $16.8 million. The increase is attributable primarily to higher sales. Gross profit was negatively impacted by an increase of $1.6 million in depreciation and amortization charges related to the implementation of fresh-start reporting. Gross profit margin for the quarter ended June 30, 2003 was 53.2% as compared to 50.8% in the corresponding prior year period. The 2.4 percentage point margin improvement is attributable primarily to the favorable mix of product sales, cost reduction initiatives and favorable currency changes offset by the above mentioned impact of fresh-start reporting.

28



        Marketing and Administrative Expense.    Marketing and administrative expense for the quarter ended June 30, 2003 increased $12.9 million to $121.0 million, or 33.5% of sales, as compared to $108.1 million, or 34.0% of sales, in the prior year period. The increase in expense was attributable primarily to $8.0 million related to changes in foreign currency exchange rates, $1.3 million of incremental depreciation and amortization related to the creation of certain intangible assets and changes in fixed asset values and lives under fresh-start reporting and increased costs related to marketing and communication initiatives.

        Research and Development Expense.    Research and development expense for the quarter ended June 30, 2003 totaled $30.5 million (8.4% of sales) and was 36.2% higher than the prior year. On a constant currency basis, research and development expense increased $6.4 million or 26.6% over the corresponding prior year period. We expect spending levels to remain approximately 8%—9% of sales and above prior year levels as we increase investments in new product development, such as the next generation Dimension® Vista™ instrument and new assays for all product lines.

        Cost Reduction Programs Expense.    In connection with cost reduction programs previously initiated, we recognized $0.9 million of expenses during the quarter ended June 30, 2002 that did not qualify for treatment as exit costs under Emerging Issues Task Force Issue No. 94-3. No such expenses were incurred in 2003.

        Restructuring Expense, net.    We recorded $0.5 million, net of restructuring reserve reversals during the quarter ended June 30, 2002. This related to an extension of the cost reduction programs approved in 2000 and 2001. No such expenses or reversals were recorded in 2003.

        Income from Operations.    Income from operations for the quarter ended June 30, 2003 increased $10.4 million to $41.0 million compared to $30.6 million in the prior year. The increase in income from operations for the quarter ended June 30, 2003 is due primarily to the impacts of improved gross profit, and lower cost reduction and restructuring expenses, offset by increased research and development spending and higher marketing and administrative expenses.

        Interest Expense.    Interest expense for the quarter ended June 30, 2003 totaled $20.5 million, a $11.7 million reduction over the corresponding prior year period. These changes are primarily due to lower interest rates and borrowing levels.

        Balance Sheet Restructuring Costs.    Balance sheet restructuring costs represent all incremental professional and bank fees associated with the reorganization of the Company's balance sheet incurred prior to the bankruptcy filing on August 1, 2002. Balance sheet restructuring costs for the quarter ended June 30, 2002 were $8.7 million. After August 1, 2002, these costs were classified as reorganization costs. No such costs were incurred in 2003.

        Income Taxes.    An income tax expense of $8.2 million, representing an effective rate of 35.3%, was recorded in the quarter ended June 30, 2003, as compared to $1.9 million, representing an effective tax rate of negative 31.7%, in the quarter ended June 30, 2002. The recording of valuation allowances had an unfavorable impact on the effective tax rate for the quarter ended June 30, 2003. The negative effective tax rate for the quarter ended June 30, 2002 is attributable to the recording of valuation allowances.

        Net Income.    The net income for the quarter ended June 30, 2003 was $15.0 million as compared to a net loss of $7.9 million in the prior year, an increase of $22.9 million. The increase in net income is due to higher income from operations, lower interest expense and balance sheet restructuring costs, offset by higher income tax expense.

29



Successor Company Six-Months Ended June 30, 2003 Compared to Predecessor Company Six-Months Ended June 30, 2002

        In order to provide a meaningful basis of comparing the six-months ended June 30, 2003 and 2002, for purposes of the following discussion, the operating results of the Successor Company for the six-months ended June 30, 2003 are compared to the Predecessor Company for the six-months ended June 30, 2002. Changes to our capital structure and the adoption of fresh-start reporting primarily affects depreciation, amortization and interest expenses.

        In the discussion below, we make comparisons on a "constant currency" basis, which is not a U.S. GAAP defined measure. We believe this measure provides for a meaningful analysis of the underlying activity since it eliminates the effect of changes in foreign currency exchange rates. When making comparisons on a constant currency basis, we have calculated the change by comparing the applicable reported current year amount to the corresponding amount from the prior year in local currency translated at the foreign currency exchange rates for the current year. "Constant currency" as defined or presented by us may not be comparable to similarly titled measures reported by other companies.

        Net Sales.    Net sales for the six-months ended June 30, 2003 totaled $704.4 million as compared to $624.2 million in the corresponding prior year period.

        Sales for each segment were as follows (in millions):

 
  Six-Months Ended
   
 
 
  June 30, 2003
  June 30, 2002
  % Change
 
GCM-North America   $ 341.4   $ 324.1   5.3 %
GCM-International     358.0     297.9   20.2 %
Global Operations     5.0     2.2   127.3 %
   
 
 
 
Total   $ 704.4   $ 624.2   12.8 %
   
 
     

        Adjusting for favorable impact of foreign currency rate changes of $50.2 million, 2003 sales increased $30.0 million or 4.4% for the six-months. On a constant currency basis, sales increased $16.5 million or 5.1% in GCM-North America, and $11.1 million or 3.2% across GCM-International locations. The increase on a constant currency basis can be primarily attributed to a $30.4 million or 7.3% increase in core chemistry sales primarily driven by Dimension® product sales globally, a $4.1 million or 3.6% increase in hemostasis product sales with the strongest growth in North America, a $4.0 million or 6.4% increase in microbiology product sales, offset by a $0.6 million or 1.6% decrease in infectious disease product sales and an $8.0 million or 18.7% decrease in sales of mature products across all segments. We define mature products as those products and services that we do not consider to be part of our core strategy and as a result, they are expected to have declining sales over time.

        The installed base of instruments placed with customers grew approximately 2.3% during the first six-months of 2003. Growth in the instrument installed base of a product line contributes to the sales growth of the corresponding reagents, consumables and service. Growth in the installed base of instruments for Dimension® RxL and Dimension® Xpand™ has driven much of the sales growth seen in our Dimension® products. Gains in the Hemostasis installed base have been driven by successes in CA-1500, CA-500, and PFA-100 instrument placements. For Microbiology, new installations of our AutoScan® and Walkaway® series of instruments continue to drive growth while the BEP®III and BEP 2000 instruments have been the primary contributors of installed base growth for the Infectious Disease product line. Improved method penetration, which results from utilizing an existing instrument base for additional tests, combined with the growth in higher priced, specialty reagents, have further contributed to our sales growth.

30



        Gross Profit.    Gross profit for the six-months ended June 30, 2003 increased $51.8 million to $371.3 million as compared to $319.5 million in the corresponding prior year period. On a constant currency basis gross profit increased $24.3 million. The increase is attributable primarily to higher sales. Gross profit was negatively impacted by an increase of $3.3 million in depreciation and amortization charges related to the implementation of fresh-start reporting. Gross profit margin for the six-months ended June 30, 2003 was 52.7% as compared to 51.2% in the corresponding prior year period. The 1.5 percentage point margin improvement is attributable primarily to favorable product mix, cost reduction initiatives at our manufacturing sites and favorable currency changes offset by the above mentioned impact of fresh-start reporting.

        Marketing and Administrative Expense.    Marketing and administrative expense for the six-months ended June 30, 2003 increased $27.5 million to $234.6 million, or 33.3% of sales, as compared to $207.1 million, or 33.2% of sales, in the prior year period. The increase in expense was attributable primarily to $15.3 million related to changes in foreign currency exchange rates, $2.7 million of incremental depreciation and amortization related to the creation of certain intangible assets and changes in fixed asset values and lives under fresh-start reporting, costs associated with SEC filings, our listing on the NASDAQ National Market, and other on-going public company costs, and a difference in the phasing of marketing costs relative to the first quarter of 2002.

        Research and Development Expense.    Research and development expense for the six-months ended June 30, 2003 totaled $56.3 million (8.0% of sales) and was 36.7% higher than the prior year. On a constant currency basis, research and development expense increased $12.7 million or 29.1% over the corresponding prior year period. We expect spending to continue to remain above prior year levels as we increase investments in new product development, such as the next generation Dimension® Vista™instrument and new assays for all product lines.

        Cost Reduction Programs Expense.    In connection with cost reduction programs previously initiated, we recognized $1.9 million of expenses during the six-months ended June 30, 2002 that did not qualify for treatment as exit costs under Emerging Issues Task Force Issue No. 94-3. No such expenses were incurred in 2003.

        Restructuring Expense.    We recognized $1.4 million of restructuring expense during the six-months ended June 30, 2002. This amount related to an extension of the cost reduction programs approved in 2000 and 2001. No such expenses were incurred in 2003.

        Income from Operations.    Income from operations for the six-months ended June 30, 2003 increased $12.5 million to $80.4 million compared to $67.9 million in the prior year. The increase in income from operations for the six-months ended June 30, 2003 is due primarily to the impacts of improved gross profit, and lower cost reduction and restructuring expenses, offset by increased research and development spending and higher marketing and administrative expenses.

        Interest Expense.    Interest expense for the six-months ended June 30, 2003 totaled $40.4 million, a $22.5 million reduction over the corresponding prior year period. These changes are primarily due to lower interest rates and borrowing levels.

        Balance Sheet Restructuring Costs.    Balance sheet restructuring costs represent all incremental professional and bank fees associated with the reorganization of the Company's balance sheet incurred prior to the bankruptcy filing on August 1, 2002. Balance sheet restructuring costs for the six-months ended June 30, 2002 were $12.5 million. After August 1, 2002, these costs were classified as reorganization costs. No such costs were incurred in 2003.

        Income Taxes.    An income tax expense of $15.0 million, representing an effective rate of 36.8%, was recorded in the six-months ended June 30, 2003, as compared to $2.6 million, representing an effective tax rate of negative 26.8%, in the six-months ended June 30, 2002. The recording of valuation

31



allowances had a negative impact on the effective tax rate for the six-months ended June 30, 2003. The negative effective tax rate for the six-months ended June 30, 2002 is attributable to the recording of valuation allowances.

        Cumulative Effect of Change in Accounting Principle.    In accordance with SFAS No. 141, we wrote off negative goodwill and recognized a $20.0 million gain as of January 1, 2002.

        Net Income.    The net income for the six-months ended June 30, 2003 was $25.8 million as compared to $7.7 million in the prior year, an increase of $18.1 million. Excluding the gain recognized in the first quarter of 2002 associated with the cumulative effect of change in accounting principle, net income increased $38.1 million, due to increased income from operations, lower interest expense and balance sheet restructuring costs, offset by higher income tax expense.

Liquidity and Capital Resources

        In order to provide a meaningful basis of comparing the quarters and six-months ended June 30, 2003 and 2002, for purposes of the following discussion, the cash flows of the Successor Company have been compared to the cash flows of the Predecessor Company.

        For the six-months ended June 30, 2003, operating activities provided cash of $107.5 million compared to $32.2 million for the six-months ended June 30, 2002. The increase is primarily due to increased income from operations, lower interest expense and balance sheet restructuring costs, offset by higher income tax expense, the increase in income before cumulative effect of change in accounting principle and improvements in working capital, specifically from the factoring of accounts receivable and improvements in the collection of accounts receivable.

        Net cash flow used for investing activities for the six-months ended June 30, 2003 is $45.3 compared to $38.3 million for the six-months ended June 30, 2002. All investing cash flows are for capital expenditures and the increase in 2003 as compared to 2002 is due primarily to an increase in the use of capital for product development and production activities and, to a lesser extent, for placing our instruments at customers' facilities.

        Financing activities for the six-months ended June 30, 2003 used net cash of $21.9 million, versus $26.2 million for the six-months ended June 30, 2002. The decrease was primarily due to lower repayments on borrowings in 2003.

        Net debt, which we define as short- and long-term debt less cash and cash equivalents and restricted cash, decreased from $728.4 million at December 31, 2002 to $664.2 million at June 30, 2003. This decrease is primarily attributable to having generated $107.5 million of cash flow from operations, which included $35.3 million of incremental draws under accounts receivable factoring facilities, offset by $45.3 million of capital expenditures. During 2003, we made prepayments on our bank debt of $20.0 million during the second quarter and $35.2 million during August.

Recent Accounting Developments

        FASB Interpretation No. 45, "Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others" ("FIN 45"), was issued in November 2002. The initial recognition and measurement provisions of this new standard, which require a guarantor to recognize a liability at inception of a guarantee at fair value, are effective on a prospective basis to guarantees issued or modified on or after January 1, 2003. The disclosure provisions, which increase the required disclosures relating to guarantees, were adopted in our consolidated financial statements as of December 31, 2002. The adoption of FIN 45 did not have a material impact on our consolidated financial statements. The nature and amount of future transactions could have a material impact on future consolidated financial statements.

32



        FASB Interpretation No. 46, "Consolidation of Variable Interest Entities" ("FIN 46"), was issued in January 2003. FIN 46 defines variable interest entities ("VIE's") and requires that the assets, liabilities, non-controlling interests, and results of activities of a VIE be consolidated if certain conditions are met. For VIE's created on or after January 31, 2003, the guidance will be applied immediately; however, we have not created any VIE's. For VIE's created before that date, the guidance will be applied at the beginning of the third quarter of 2003. The new rules may be applied prospectively with a cumulative-effect adjustment as of the beginning of the period in which it is first applied or by restating previously issued financial statements for one or more years with a cumulative-effect adjustment as of the beginning of the first year restated. As the Company does not have any VIE's, FIN 46 does not currently have an effect on the Company's consolidated financial statements.

        In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." SFAS No. 149 amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts and for hedging activities under SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities." SFAS No. 149 is effective for contracts entered into or modified after June 30, 2003, and for hedging relationships designated after that date. The provisions of SFAS No. 149 should be applied prospectively. We are in the process of evaluating the potential effect of this recently issued accounting pronouncement on our future consolidated financial statements.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

        The Company's 2002 Annual Report on Form 10-K contains quantitative and qualitative disclosures about market risk as of and for the year ended December 31, 2002. No material changes in the Company's market risk have occurred since December 31, 2002.


ITEM 4. CONTROLS AND PROCEDURES.

        (a)   Evaluation of Disclosure Controls and Procedures.    Our management, including our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as defined by Rules 13a-14(c) and 15d-14(c) of the Securities and Exchange Act of 1934, as amended. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this quarterly report, our disclosure controls and procedures were effective to ensure that information we are required to disclose in our filings with the Securities and Exchange Commission under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms, and to ensure that information we are required to disclose in the reports that we file under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. It should be noted, however, that the design of any system of controls is limited in its ability to detect errors, and there can therefore be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

        (b)   Changes to Internal Controls and Procedures for Financial Reporting.    During the period covered by this quarterly report, there have been no changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.

33



PART II

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.


 
  Votes
For

  Votes
Withheld
or Against

  Abstentions
and Broker
Non-Votes

Election of Directors            
James Reid-Anderson   37,876,857   8,595   0
Jeffrey D. Benjamin   37,885,452   0   0
Alan S. Cooper   37,885,452   0   0

 
  Votes
For

  Votes
Withheld
or Against

  Abstentions
and Broker
Non-Votes

Approve the Amendment of the Corporation's Certificate of Incorporation to increase the number of authorized shares   21,267,021   66,219   16,552,212

 
  Votes
For

  Votes
Withheld
or Against

  Abstentions
and Broker
Non-Votes

Approval of the Dade Behring Nonemployee Directors' Deferred Stock Compensation Plan   37,532,826   87,783   264,843

 
  Votes
For

  Votes
Withheld
or Against

  Abstentions
and Broker
Non-Votes

Approval of the Dade Behring Employee Stock Purchase Plan   37,602,809   17,800   264,843

34


ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K.

35



SIGNATURE

        Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

    DADE BEHRING HOLDINGS, INC.

 

 

By:

 

/s/  
JOHN M. DUFFEY      
John M. Duffey
Senior Vice President and Chief Financial Officer

August 13, 2003

 

 

 

 

36



EXHIBIT INDEX

EXHIBIT
NUMBER

  EXHIBIT TITLE
3.1   Fourth Amended and Restated Certificate of Incorporation of Dade Behring Holdings, Inc.

31.1

 

Certification of James W.P. Reid-Anderson, Chairman, President and Chief Executive Officer, pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

 

Certification of John M. Duffey, Senior Vice President and Chief Financial Officer, pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

 

Certification of James W.P. Reid-Anderson, Chairman, President and Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

 

Certification of John M. Duffey, Senior Vice President and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

37




QuickLinks

APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PRECEDING FIVE YEARS
DADE BEHRING HOLDINGS, INC. JUNE 30, 2003 FORM 10-Q—TABLE OF CONTENTS
Dade Behring Holdings, Inc. Condensed Consolidated Balance Sheets
Dade Behring Holdings, Inc. Condensed Consolidated Statements of Operations and Comprehensive Income
Dade Behring Holdings, Inc. Condensed Consolidated Statements of Operations and Comprehensive Income
Dade Behring Holdings, Inc. Condensed Consolidated Statement of Changes in Shareholders' Equity (Unaudited) (Dollars in millions, except share-related data)
Dade Behring Holdings, Inc. Condensed Consolidated Statements of Cash Flows
Dade Behring Holdings, Inc. Notes To Condensed Consolidated Financial Statements (unaudited)
Successor Company Condensed Consolidating Balance Sheet June 30, 2003
Successor Company Condensed Consolidating Balance Sheet December 31, 2002
Successor Company Condensed Consolidating Statement of Operations Quarter Ended June 30, 2003
Successor Company Condensed Consolidating Statement of Operations Six-months Ended June 30, 2003
Predecessor Company Condensed Consolidating Statement of Operations Quarter Ended June 30, 2002
Predecessor Company Condensed Consolidating Statement of Operations Six-months Ended June 30, 2002
Successor Company Condensed Consolidating Statement of Cash Flows Six-months Ended June 30, 2003
Predecessor Company Condensed Consolidating Statement of Cash Flows Six-months Ended June 30, 2002
SIGNATURE
EXHIBIT INDEX